Recently, several articles reported incidental findings at 2-[18F] FDG PET/CT in patients who
have received COVID-19 vaccinations, including hypermetabolic axillary lymph nodes …

Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is
important to explore the possible impact of approved SARS-CoV-2 mRNA vaccines on …

We aimed to predict the presence of vaccine-induced hypermetabolic lymph nodes (v-HLNs)
on 18F-FDG PET/CT after coronavirus disease 2019 (COVID-19) vaccination and determine …

Simple Summary The mass COVID-19 vaccination led to unexpected PET findings. Notably,
axillary and interpectoral lymphadenopathies ipsilateral to the vaccine inoculation were …

A 79-year-old man with a history of prostate adenocarcinoma treated with prostatectomy
underwent 18 F-FCH PET/CT for restaging purpose, which was negative for relapse but …

Austria started its COVID-19-vaccination program in December 2020 with three different
vaccines. As the vaccination program continues, we encountered increased 2-[18F] FDG …

The coronavirus disease 2019 (COVID-19) pandemic is an ongoing global emergency
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus …

In the following report, we describe 11 patients with various diagnoses and different
treatment statuses (newly diagnosed, receiving treatment, or follow-up) of oncological …

Pfizer/BioNTech (BNT162b2) is a messenger RNA (mRNA) vaccine that is highly effective in
preventing the most severe outcomes of COVID-19 infection. Nucleoside-modified severe …

Methods:: The collected data of 220 eligible vaccinated patients (127 with BioNTech/Pfizer
BNT162b2, 61 with Moderna, and 32 with AstraZeneca) examined with F18-FDG-PET/CT …